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A Protein (ORF2) Encoded by the Latency-Related Gene of Bovine
Herpesvirus 1 Interacts with DNA
Daraporn Pittayakhajonwut, Devis Sinani, Clinton Jones
School of Veterinary Medicine and Biomedical Sciences, Nebraska Center for Virology, University of Nebraska, Lincoln, Nebraska, USA
Bovine herpesvirus 1 (BHV-1), like other members of the Alphaherpesvirinae subfamily, establishes latency in sensory neurons.
The virally encoded latency-related RNA (LR-RNA) is expressed abundantly in latently infected sensory neurons and encodes
several proteins, including ORF2. An LRmutant virus with stop codons at the amino terminus of ORF2 does not reactivate from
latency after treatment with the synthetic corticosteroid dexamethasone, in part because it induces higher levels of apoptosis
during the establishment of latency. ORF2 inhibits apoptosis, interacts with three cellular transcription factors (Notch1, Notch3,
and C/EBP-), and interferes with Notch-mediated signaling. Consequently, we predict that ORF2 expression is crucial for the
latency reactivation cycle in cattle. In this study, we tested whether ORF2 interacts with nucleic acids, because it contains 18%
basic amino acids and localizes to the nucleus. A subset of ORF2 proteins was associated with chromatin and preferentially asso-
ciated with single-stranded DNA in transfected neuroblastoma cells (Neuro-2A). Alanine substitution of serine, threonine, and
tyrosine residues in ORF2 increased the steady-state protein levels in Neuro-2A cells, and this protein preferentially interacted
with double-stranded DNA. Certain in-frame transposon insertion mutants did not interact with DNA as efficiently as wild-type
(wt) ORF2 did. ORF2 purified from bacteria under denaturing conditions preferentially interacted with double-stranded DNA,
suggesting that the interaction between ORF2 and DNAwas direct. In contrast, ORF2 purified under native conditions preferen-
tially interacted with single-stranded DNA.We suggest that interactions between ORF2 and DNAmediate certain aspects of the
latency reactivation cycle.
Bovine herpesvirus 1 (BHV-1), a member of the Alphaherpes-virinae subfamily, causes significant economic losses to the
cattle industry (1). For example, the ability of BHV-1 to suppress
the immune system can result in life-threatening bacterial pneu-
monia. This polymicrobial disease is known as the bovine respi-
ratory disease complex (reviewed in references 2 and 3). When
acute infection occurs onmucosal linings within the ocular, nasal,
or oral cavity, sensory neurons within trigeminal ganglia (TG)
become the primary site for BHV-1 latency. Abundant viral gene
expression (4) and infectious virus (5) are detected during acute
infection, but viral gene expression is subsequently extinguished
and latency is established (3, 6). Stress (due to confinement, trans-
portation of cattle, restriction of food and water, or weaning) in-
creases corticosteroid levels and can initiate reactivation from la-
tency (7). Administration of the synthetic corticosteroid
dexamethasone to calves latently infected with BHV-1 reproduc-
ibly induces reactivation from latency (5, 6, 8–11). Induction of
lytic cycle viral gene transcription is also consistently detected in
TG neurons of calves latently infected with BHV-1 following
dexamethasone treatment.
Abundant expression of the BHV-1-encoded latency-related
RNA (LR-RNA) occurs in latently infected neurons; however, in-
fectious virus is not detected by standard assays (because of main-
tenance of latency) (6, 8, 9, 11–13). LR-RNA is antisense relative to
the bICP0 gene and has a unique start site in TG (14, 15). The LR
gene has two open reading frames (ORF1 and ORF2) and two
reading frames that lack an initiating ATG (RF-B and RF-C). An
LR mutant virus strain with 3 stop codons at the N terminus of
ORF2 results in diminished clinical symptoms and reduced virus
shedding from the eye, TG, or tonsils of infected calves (5, 16, 17).
ORF1, ORF2, and RF-C are expressed when bovine cells are in-
fected with wild-type (wt) or LR-rescued virus but have reduced
or no expression following infectionwith the LRmutant virus (18,
19). Wild-type LR gene expression is necessary for dexametha-
sone-induced reactivation from latency (5), in part because the
antiapoptosis activity ofORF2 appears to be crucial for the latency
reactivation cycle (20–23). Additional studies demonstrated that
ORF2 interacts with the cellular transcription factors Notch1,
Notch3, and C/EBP- (19, 24, 25). ORF2 reduces Notch-medi-
ated trans-activation of the bICP0 early promoter and the glyco-
protein C promoter. ORF2 also promotes neurite differentiation
in the presence ofNotch (26), which correlates withmaintaining a
mature neuronal phenotype. Transposon insertion mutants and
site-directed mutants of ORF2 were prepared and analyzed (23)
(see Fig. 1 for a schematic of the mutants used for this study).
These studies revealed thatORF2 contains sequences necessary for
inhibiting apoptosis; conversely, nonoverlapping sequences were
identified that interfere with Notch-mediated trans-activation of
the bICP0 early promoter (23). In addition to ORF2, LR-specific
micro-RNAs inhibit bICP0 expression and apoptosis (27, 28).
Collectively, these studies indicate that the LR gene promotes the
establishment and maintenance of latency by enhancing the sur-
vival of infected neurons.
In this study, we found that ORF2 extracted from mouse neu-
roblastoma cells (Neuro-2A cells) preferentially interacted with
single-stranded DNA (ssDNA)-cellulose compared to double-
stranded DNA (dsDNA)-cellulose. In contrast, a mutant ORF2
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protein with all potential phosphorylation sites replaced with ala-
nine residues preferentially interacted with dsDNA. A similar re-
sult was observed when the five consensus protein kinase A (PKA)
and/or PKC phosphorylation sites were mutated to alanine. Two
transposon insertionmutants in the amino-terminal half of ORF2
did not interact withDNAas efficiently as wtORF2 did, indicating
that certain domains are necessary for DNA binding. ORF2 par-
tially purified under denaturing conditions from Escherichia coli
preferentially interacted with dsDNA-cellulose, while ORF2 par-
tially purified under nondenaturing conditions preferentially in-
teracted with ssDNA-cellulose. When ORF2 was purified from
bacteria under denaturing conditions, dsDNA, but not RNA, in-
hibited binding to dsDNA-cellulose. Collectively, these studies
provide evidence that ORF2 interacts with DNA, suggesting that
this function plays a role in the latency reactivation cycle.
MATERIALS AND METHODS
Cells. Murine neuroblastoma cells (Neuro-2A) were grown in Earle’s
modified Eagle’s medium (EMEM) supplemented with 5% fetal bovine
serum (FCS), penicillin (10 U/ml), and streptomycin (100 g/ml).
ORF2 expression constructs and mutants used in this study. The
mammalian ORF2 expression construct was generated in the vector
pCMV-Tag-2B (Stratagene). From this vector, a Flag epitope is expressed
at the N terminus of ORF2, and the human immediate-early (IE) cyto-
megalovirus (CMV) promoter drives expression of ORF2. Further details
of this plasmid were described previously (21–23). Two ORF2 phosphor-
ylation mutants were synthesized. ORF2-AP contains alanine mutations
at all potential phosphorylation sites (Ser8, Ser31, Tyr39, Thr40, Ser71,
Ser79, Ser 98, Ser116, Ser117, Ser120, Ser121, Ser134, Ser 138, Thr174,
and Ser176). ORF2-P contains alanine substitutions at consensus cyclic
AMP (cAMP)-dependent PKA and/or serine/threonine-specific PKC
(Ser31, Thr40, Ser71, Ser121, and Thr174) sites. ORF2-P also contains
alanine substitutions of Tyr39 and Ser120, which are adjacent to the con-
sensus PKA/PKC sites. Bothmutants were synthesized by IDT (Coralville,
IA) and ligated into the ORF2 expression vector (pCMV-Tag-2B; Strat-
agene) at the BamHI-HindIII restriction enzyme sites.
Transposon mutants of ORF2 were described previously (23) (see
Fig. 1 for a schematic of the locations of the transposon insertion con-
structs used in this study). In brief, a 57-bp linker (Epicentre) was ran-
domly inserted into the ORF2 DNA sequences according to the manufac-
turer’s instructions. The site of transposon insertion was determined by
FIG 1 Schematic of LR gene and expression of ORF2 in transfected Neuro-2A cells. (A) Schematic of the LR gene. A partial restriction map of the LR gene is
shown. The numbering system for the LR gene and the position of ORF2 was derived from a previous study (12). The locations of LR-RNA start sites were
previously published (14, 15). The positions of the 3= terminus of bICP0 and the bICP0 stop codon were previously described (53–55). (B) Locations of ORF2
transposonmutants used in this study. Construction and cloning of ORF2 transposon insertionmutants and an NLS deletionmutant were described previously
(23). Vertical lines with numbers indicate the nucleotide positions of the respective transposon insertions. The relative position of the NLS, which spans
nucleotides 192 to 210 (amino acids 64 to 70), is denoted by the checkered rectangle. (C) Amino acid sequence of ORF2. The black-shaded amino acids are basic
amino acids, the underlined amino acids contain the NLS, and the gray-shaded amino acids are the threonine or serine residues that are within consensus PKA
or PKC phosphorylation sites. (D) Neuro-2A cells were transfected with the wt ORF2 construct, the ORF2-P construct, or the ORF2-AP construct. Forty-eight
hours after transfection, cell lysate was prepared and wt or mutant ORF2 detected by Western blotting using a Flag-specific monoclonal antibody.
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DNA sequencing, and the respective inserts were recloned into the Flag-
tagged pCMV-Tag-2B vector at the BamHI-Sal site. The Flag-tagged mu-
tant constructs were confirmed by sequencing. Each transposon mutant
expressed a full-length ORF2 with a 19-amino-acid transposon insertion
in frame with ORF2. The transposon mutants used for this study were
previously shown to be expressed in Neuro-2A cells, at levels similar to
those of wt ORF2 (23).
ORF2 was also synthesized by IDT as a codon-optimized protein for
bacterial expression. Briefly, codon-optimized ORF2 was synthesized
with XhoI and HindIII sites introduced at the 5= and 3= ends of the gene,
respectively. ORF2 sequences were then cloned downstream of six histi-
dine residues and an Xpress epitope in the vector (pRSET-A; Invitrogen),
at unique XhoI and HindIII sites.
Western blot analysis. Neuro-2A cells in 60-mm dishes were trans-
fected with the designated plasmids. Forty-eight hours after transfection,
cells were collected, washed once with phosphate-buffered saline (PBS),
and suspended in lysis buffer (50 mMTris-HCl, pH 8, 150 mMNaCl, 1%
Triton X-100) with protease inhibitors (Roche). Cell lysate was subse-
quently incubated at 4°C for 30 min and centrifuged at 16,000 g for 10
min at 4°C, and the supernatant was collected. The pellet was suspended
in lysis buffer with Benzonase (Sigma), incubated at 4°C for 30 min, and
then centrifuged for 10 min at 16,000  g, and the supernatant was col-
lected. The pellet was suspended in RIPA buffer (50 mM Tris-HCl, pH 8,
500 mM NaCl, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate
[SDS], 1% Triton X-100) and incubated at 4°C for 30 min with rotation.
The lysate was centrifuged at 16,000 g for 10 min, and the supernatant
was collected. The pellet or the respective samples from each fractionwere
boiled in Laemmli sample buffer for 5min, and all samples were separated
in a 12% SDS-polyacrylamide gel. Immunodetection of ORF2 and its
mutants was performed using amouse anti-Flag antibody (F1804; Sigma)
(1:500). Endogenous cyclin-dependent kinase 2 (cdk2) was used as a nu-
clear control and was detected using a mouse anti-cdk2 antibody (SC-
6248; Santa Cruz).
ORF2 protein extraction and DNA binding assays by affinity chro-
matography. The pBad/His expression vector with a six-histidine N-ter-
minal tag (Invitrogen) was used to overexpress ORF2 in Escherichia coli
BL21. A bacterial codon-optimized ORF2 was synthesized by IDT and
then transformed intoEscherichia coliBL21. The recombinant proteinwas
expressed by induction with isopropyl--D-thiogalactopyranoside
(IPTG) for 4 h at mid-log phase. The histidine-tagged protein was then
purified throughNi2-agarose beads under nondenaturing or denaturing
conditions, according to the manufacturer’s instructions (Clontech).
Briefly, cells were lysed by sonication in binding buffer (50mMphosphate
buffer [pH7.4], 300mMNaCl, and 10mM imidazole), and cell debris was
removed by centrifugation at 46,500 g for 30min. The supernatant was
mixed with a 50% slurry of Ni2-agarose beads for 2 h at 4°C. After the
beads were washed 5 times with wash buffer (50 mM phosphate buffer
[pH 7.4], 500 mM NaCl, and 20 mM imidazole), bound protein was
eluted with 0.5 M imidazole in binding buffer.
For partial purification of bacterially expressed ORF2 by denaturing
purification, 8M urea was added during binding and the respective wash-
ing steps. ORF2 in 8 M urea was then subjected to dialysis in a buffer
containing 20mMTris-HCl (pH 7.4), 150mMNaCl, 1mMEDTA, 1mM
-mercaptoethanol, 10% glycerol, and 100 g/ml bovine serum albumin
(BSA) for 16 h. This protein was operationally defined as renatured and
was then used forDNA chromatography studies. The purity of the protein
was examined by silver staining, and Western analysis of ORF2 was per-
formed using an anti-Xpress antibody to confirm which protein was
ORF2 (Invitrogen).
The mammalian ORF2 expression construct was transfected into
Neuro-2A cells by usingTransIT-Neural (Mirus,Madison,WI) according
to the manufacturer’s instructions. Forty-eight hours after transfection,
monolayers were washed twice with cold phosphate-buffered saline,
scraped from plates, and then lysed in cell lysis buffer (20 mM Tris-HCl
[pH 7.4], 10 mMMgCl2, 500 mMNaCl, 1 mM EDTA, 1 mM -mercap-
toethanol, 10%glycerol, and 100g/ml BSA). The lysatewas sonicated for
15 s prior to incubating with rotation at 4°C for 30 min. Cell debris was
centrifuged at 46,500 g for 15 min. The supernatant was subsequently
desalted against dialysis buffer (20mMTris-HCl [pH 7.4], 150mMNaCl,
1 mM EDTA, 1 mM -mercaptoethanol, 10% glycerol, and 100 g/ml
BSA) and then used for DNA chromatography. ORF2 was detected by
Western blotting using an anti-Flag antibody (Sigma, St. Louis, MO).
DNA-cellulose chromatography was performed by incubating 100g
of ds- or ssDNA-cellulose (Sigma) with 100g of Ni2-purifiedORF2 for
2 h or 1 mg of mammalian cell lysate containing ORF2 or ORF2 mutants
for 24 h at 4°C in binding buffer (20mMTris-HCl [pH 7.4], 50mMNaCl,
1 mM -mercaptoethanol, 1 mM EDTA, 100g/ml BSA, 10% glycerol, 1
mM phenylmethylsulfonyl fluoride [PMSF], and 1 protease inhibitor
[Roche]). After the protein was incubated with the designated DNA-cel-
lulose beads, the beads were washed 5 times in binding buffer containing
100mMNaCl, and bound proteins were eluted with Laemmli SDS-PAGE
buffer. Samples were subjected to electrophoresis by SDS-PAGE and an-
alyzed by Western blotting. To determine the preference of ORF2 for
nucleic acid binding, yeast total RNA or herring dsDNA was added at
different concentrations to the DNA-cellulose column with the extract
prior to the washing step in competition experiments. DNA-free cellulose
(Sigma) was used as a negative control.
RESULTS
ORF2 is a basic protein that localizes to the nucleus.ORF2 is the
first open reading frame downstream of the start site of LR-RNA
(Fig. 1A); the coding sequences of ORF2 completely overlap the
bICP0 transcript, and ORF2 is expressed in a subset of latently
infected neurons (29, 30). The nuclear localization signal (NLS)
within ORF2 (Fig. 1B) is identical to the NLS in the transcription
factor Sp1 (31), and deletion of amino acids comprising the ORF2
NLS prevents nuclear localization (23). ORF2 contains approxi-
mately 18% basic amino acids (Fig. 1C, black-shaded amino ac-
ids). BLAST analysis of the entire ORF2 sequence did not reveal
extensive similarity to other known proteins.
For the studies described below, we used a mouse neuroblas-
toma cell line (Neuro-2A) because these cells are readily trans-
fected, ORF2 is readily expressed in these cells, and ORF2 pro-
motes neurite sprouting in these cells following growth factor
withdrawal (23, 25, 26). ORF2 contains five consensus PKA and
PKC phosphorylation sites (Fig. 1C, gray-shaded amino acids).
Activation of PKA stimulates herpes simplex virus 1 (HSV-1) re-
activation from latency (32, 33), suggesting that PKA regulates
ORF2 phosphorylation and certain aspects of the BHV-1 latency
reactivation cycle. Consequently, twophosphorylationmutants of
ORF2 were synthesized and their expression compared to that of
wt ORF2 in transfected Neuro-2A cells. ORF2-AP contains ala-
nine mutations of all serine, threonine, and tyrosine residues, and
ORF2-P contains all of the PKA/PKC consensus sites mutated to
alanine (23). ORF2-P also contains mutations in Tyr39 and
Ser120, which are adjacent to PKA/PKC sites. In transfected
Neuro-2A cells, wt ORF2 migrated as 20- and 33-kDa bands
(Fig. 1D, closed circles). The ORF2-P and ORF2-AP mutant pro-
teinswere expressed at higher steady-state levels (open circle) than
that of wt ORF2, which is consistent with a recent study (23). The
predominant band expressed by ORF2-P and ORF2-APmigrated
as a slightly larger protein than the faster-migratingwtORF2 band
andwas the only band detected unless the blot was overexposed to
allow detection of wt ORF2. The predicted molecular mass of
ORF2 is approximately 20 kDa. For cells transfected with the
blank expression vector, the Flag-specific antibody did not readily
detect specific bands. When ORF2 is expressed in Neuro-2A cells,
ORF2 Binds DNA
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it localizes to the nuclear periphery (23, 25). When all of the po-
tential phosphorylation sites (ORF2-AP) or the 5 consensus PKA
or PKC phosphorylation sites were mutated to alanine, the mu-
tant proteins and wt ORF2 had similar subnuclear localizations as
judged by confocal microscopy (23; our unpublished data).
To further examine the localization of ORF2 in transfected
Neuro-2A cells, biochemical fractionation was performed and
compared to that of a protein that localizes to the nucleus, i.e.,
cdk2 (Fig. 2A andB). Treatment of cells with 0.15MNaCl released
most of the ORF2 and cdk2 (Fig. 2A and B). Readily detectable
levels of the high-molecular-weight ORF2-specific bands were re-
leased from the nucleus after DNase I treatment followed by ex-
traction with RIPA buffer. In contrast to the case for cdk2, ORF2-
specific bands were readily detected in the nuclear pellet even after
extraction with RIPA buffer.
Subsequent studieswere performed to compare the subnuclear
localization of certain mutants to that of wt ORF2. Three trans-
poson mutants, ORF2-134, ORF2-240, and ORF2-529, were cho-
sen for this study because ORF2-134 and ORF2-240 do not stim-
ulate viral promoters or productive infection and do not promote
neurite formation in the presence of Notch (23, 26). Conversely,
ORF2-529 behaves like wt ORF2. Most of the ORF2-134 and
ORF2-240 protein was released after treatment with 0.15 MNaCl
andDNase I (Fig. 2A and B). ORF2-134 was not readily detectable
following extractionwith RIPA buffer andwas not associatedwith
the final pellet. ORF2-529 was released following digestion of nu-
clei with DNase I and extraction with RIPA and was found in the
pellet, indicating that this protein was associated with chromatin
and/or nuclear structures. Relative to wt ORF2, the alanine sub-
stitution mutants (ORF2-P and ORF2-AP) contained high levels
of protein that were tightly associated with the nucleus (Fig. 2A
and B). The relative levels of the 33-kDa ORF2-specific band var-
ied from experiment to experiment, and the fact that this higher-
molecular-mass band was not detected in cells transfected with
ORF2-P or ORF2-AP further suggested that ORF-2-specific high-
molecular-mass bands might be due to phosphorylation. In sum-
mary, biochemical fractionation demonstrated that there were
differences in the subnuclear localization of specific ORF2 mu-
tants relative to that of wt ORF2. These subtle differences in nu-
clear localization were not readily observed by confocal micros-
copy (23).
ORF2 expressed in Neuro-2A cells interacts with DNA. Re-
lease of ORF2 from transfected cells by DNase I treatment added
support to our prediction that ORF2 interacts with DNA or nu-
clear structures that contain DNA. To test whether ORF2 inter-
acted with DNA, we performed DNA binding assays with DNA-
cellulose. For the DNA binding assays, a Flag-tagged ORF2- or
mutant ORF2-expressing plasmid was released from transfected
cells with a buffer that contained 500mMNaCl, and this lysatewas
then dialyzed. Under these conditions, we believe that ORF2 and
the designated mutant ORF2 proteins were not denatured. We
compared the ability of ORF2 to interact with ssDNA versus ds-
DNA coupled to cellulose, because certain DNA binding proteins
preferentially bind ssDNA versus dsDNA (reviewed in reference
34). Cell lysate was incubated with DNA-cellulose beads, and
binding ofORF2 toDNA-cellulose beadswas detected byWestern
blotting using a Flag-specific monoclonal antibody. In several in-
dependent studies, ORF2 prepared from transfected Neuro-2A
cells preferentially interactedwith ssDNAbeads relative to dsDNA
beads or blank cellulose beads (Fig. 3A). As expected, ORF2-spe-
cific bands were not detected by the Flag monoclonal antibody in
mock-transfected cells (Fig. 3A, “mock” lanes).
To identify domains that were important for interacting with
DNA,we utilized previously describedORF2mutants (23, 26) and
tested them for the ability to bind DNA. Although ORF2NLS
does not localize to the nucleus (23), it interacted with both
FIG 2 Localization of ORF2 in transfected Neuro-2A cells after biochemical fractionation. (A) Neuro-2A cells were transfected with wt ORF2 or the designated
ORF2mutant construct. Forty-eight hours after transfection, cells were collected and processed forWestern blot analysis as designated inMaterials andMethods.
Asterisks denote wt ORF2- andmutant ORF2-specific bands. One hundredmicrograms of protein from the indicated fraction was loaded in each lane. cdk2 was
used as a control for a protein residing in the nucleus. (B) The ORF2 band intensity in each lane in panel A was quantified using a Bio-Rad FXmolecular imager.
The graph is representative of three independent experiments and presents percentages of the total ORF2 detected in transfected cells.
Pittayakhajonwut et al.
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ssDNA and dsDNA, but with reduced affinity (Fig. 3B).
ORF2NLS has preferentially interacted with ssDNA-cellulose
beads in several independent experiments, similar to wt ORF2.
Previous studies demonstrated that the ORF2NLS protein mi-
grated as the larger protein species (23). Three in-frame trans-
poson insertion mutants were examined: ORF2-134, ORF2-240,
and ORF2-529 (Fig. 3C). ORF2-134 and ORF2-240 have inser-
tions in the N-terminal region (Fig. 1B), which is adjacent to the
NLS, and are defective in known ORF2 functions (23, 26). ORF2-
529 contains an in-frame transposon insertion in the C-terminal
part of ORF2 and functions similarly to wt ORF2. ORF2-134 and
-240 were unable to bind dsDNA-cellulose, and only a weak inter-
action with ssDNA-cellulose was detected (Fig. 3C). In contrast,
ORF2-529 interacted with both ssDNA- and dsDNA-cellulose,
but preferentially with ssDNA-cellulose (Fig. 3C), similar to the
case with wtORF2. In contrast to the othermutants andwtORF2,
the ORF2-AP and ORF2-P mutants preferentially interacted with
dsDNA-cellulose. In general, this study provided evidence that wt
ORF2preferentially interactedwith ssDNA-cellulose compared to
dsDNA-cellulose. The N-terminal domain of ORF2 was impor-
tant for interacting with DNA, whereas putative PKA/PKC con-
sensus phosphorylation sites in ORF2 influenced the interaction
with dsDNA- versus ssDNA-cellulose.
ORF2 purified from bacteria interacts with DNA. Although
the studies in Fig. 3 indicated that ORF2 interacted with DNA, the
fact that ORF2 interacts with three cellular transcription factors,
i.e., Notch1, Notch3, and c/EBP- (25, 35), suggested that the
interaction between ORF2 and DNA occurred by an indirect
mechanism. To address this concern, we overexpressed His-
tagged ORF2 in E. coli, purified this protein, and performed DNA
chromatography. Following nickel-affinity chromatography of
proteins extracted from E. coli under denaturing conditions,
ORF2 was the predominant protein eluted from the Ni2 column
(Fig. 4A). The lower-molecular-weight proteins migrating below
intact ORF2 are likely degraded ORF2 products, because an anti-
body directed against a region that lies between a polyhistidine
tract and an Xpress-specific antibody epitope specifically recog-
nized these bands (Fig. 4B and C, lane Ni2). As expected, ORF2
was not readily detected in the unbound extract (Fig. 4C, lane
unbound).
We purifiedORF2 under denaturing conditions to rule out the
possibility that it interacted with a bacterial DNA binding protein
and then consequently interacted with DNA. Following purifica-
tion of ORF2 under denaturing conditions, dialysis was per-
formed to promote renaturing of ORF2. ORF2 prepared under
these conditions preferentially interacted with dsDNA (Fig. 5A).
As expected, ORF2 purified under denaturing conditions was not
readily detected when it was incubated with blank cellulose beads.
WhenORF2 was purified by Ni2 chromatography under nonde-
naturing conditions, the ORF2 prepared under these conditions
preferentially interacted with ssDNA-cellulose and, to a lesser ex-
tent, dsDNA-cellulose (Fig. 5B). As expected, ORF2 purified from
E. coli under nondenaturing conditions did not interact with
blank cellulose beads. We suggest that ORF2 partially purified
from E. coli under denaturing conditions and then dialyzed had a
different conformation from that ofORF2partially purified under
nondenaturing conditions, because it preferentially interacted
with dsDNA-cellulose. It is also conceivable that ORF2 prepared
under nondenaturing conditions copurified with a bacterial pro-
tein that enhanced the association with ssDNA.
To examine the specificity of the DNA binding activity of
ORF2, competition studies were performed using ORF2 prepared
FIG 3 ORF2 interacts with DNA following extraction from transfected Neuro-2A cells. Neuro-2A cells (5 106) were transfected with plasmids expressing wt
ORF2 (A) or ORF2 mutants (B and C). DNA chromatography was performed as described in Materials and Methods, with ssDNA-cellulose, dsDNA-cellulose,
or blank cellulose beads. As a negative control, Neuro-2A cells were transfected with just transfection reagent. Onemilligram of cell extract was used for cells that
expressed wt and mutant ORF2, except for the ORF2-P and ORF2-AP mutants, for which 300 g of cell extract was incubated with DNA-cellulose. A lower
concentration of cell extract was used after transfection with ORF2-AP or ORF2-P because the respective plasmids expressed higher levels of ORF2. Input (I)
equivalent to 10% cell extract used in the experiments was loaded in the respective panels to verify that ORF2 was expressed. Expression of wt or mutant ORF2
in Neuro-2A cells was analyzed by Western blotting using an anti-Flag antibody. Asterisks denote ORF2-specific bands. Molecular size standards denote the
positions of ORF2-specific bands.
ORF2 Binds DNA
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from E. coli under denaturing conditions. In these experiments,
double-strandedDNA from herring or total yeast RNAwas added
in increasing amounts (12.5- to 250-fold excess) to dsDNA-cellu-
lose columns, along with partially purified ORF2. Binding of
ORF2 to dsDNA-cellulose beads was competed for by dsDNA
(Fig. 6). In contrast, yeast RNA did not have an effect on the levels
of ORF2 that interacted with dsDNA-cellulose beads, even when
the RNA was present in 250-fold excess. Similar results were ob-
tained when ORF2 was purified under nondenaturing conditions
(data not shown). In summary, these studies suggested that ORF2
interacts directly with DNA.
DISCUSSION
In this study, we have provided evidence thatORF2, in the absence
of other viral proteins, stably associates with DNA. Native ORF2
FIG 4 Expression and purity of histidine-tagged ORF2 during Ni2 agarose purification. ORF2 was expressed in E. coli as described inMaterials andMethods. A cell
lysate from bacteria was prepared and ORF2 partially purified using a Ni2 column under denaturing conditions as described in Materials and Methods. Two
micrograms of protein from the indicated sample was separated by 12% SDS-PAGE and visualized by silver staining (A) or analyzed byWestern blotting (B). Standard
molecular sizemarkers were used to estimate the sizes of the respective proteins. Lanes: extract, cell extract from induced BL21 cells; unbound, fraction after the extract
was incubatedwith theNi2 column;Ni2, proteins bound to theNi2 columnprior to elution. Panel C is a longer exposure of panel B and is shown to visualizeORF2
in the total extract.
FIG 5 ORF2 expressed in bacteria interacts with DNA. (A) ORF2 was partially
purifiedbyNi2 columnchromatographyunder denaturing conditions. The par-
tially purified ORF2 protein (approximately 1 g total protein) was incubated
with dsDNA-cellulose, ssDNA-cellulose, or blank cellulose as described in Mate-
rials and Methods. After extensive washing, bound proteins were eluted using
SDS-PAGE buffer. Samples were separated by 12% SDS-PAGE, proteins were
transferred to nylon membranes, and ORF2 was detected using an anti-Xpress
antibody. Molecular size markers are shown on the left. (B) ORF2 was partially
purified by Ni2 column chromatography under native conditions. The partially
purified ORF2 protein (approximately 2g protein) was incubated with the des-
ignated cellulose beads and analyzed as described for panelA.The results in panels
A and B are representative of at least 3 independent experiments.
FIG 6 dsDNA, but not RNA, competes for binding of ORF2 to dsDNA-
cellulose. DNA binding reactions were performed with dsDNA-cellulose and
ORF2 partially purified by a Ni2 column under denaturing conditions (ap-
proximately 1g protein).Where indicated, increasing concentrations (g) of
herringDNA (ds-DNA) or yeast RNAwere added to the binding reactionmix.
Blank cellulose beads (cellulose lane) were used as a negative control to verify
that ORF2 did not stick to the beads. The results are representative of four
independent experiments.
Pittayakhajonwut et al.
5498 jvi.asm.org Journ
(purified from bacteria or expressed in transiently transfected
Neuro-2A cells) interacted preferentially with ssDNA (see Fig. 7A
for a schematic summarizing these studies). Conformational
changes, as a result of partial purification of ORF2 under denatur-
ing conditions and then dialysis to allow refolding of the protein,
yielded a protein that preferentially interacted with dsDNA. Mu-
tating serine or threonine residues in the consensus PKA/PKC
phosphorylation sites inORF2 to alanine (ORF2-P) also appeared
to alter the conformation of ORF2, as the mutant protein prefer-
entially bound dsDNA versus ssDNA. Phosphorylation-depen-
dent degradation of the oncogene c-Myc (36), the Notch1 inter-
cellular domain (37), and the cyclin-dependent kinase inhibitor
p27 (38) occurs, suggesting that cellular protein kinases phos-
phorylate PKA/PKC consensus sites inORF2 andpromote its deg-
radation via the ubiquitin pathway. In spite of the alanine substi-
tutions in ORF2-P, the resulting protein still inhibits apoptosis
and Notch-mediated signaling properties with similar efficiencies
to those of wt ORF2 (23, 26). However, ORF2-P interfered with
activation of aNotch-dependent promoter, hairy enhancer of split
5, less efficiently than wt ORF2 did (23, 26).
Previous studies have demonstrated that ORF2 directly inter-
acts with Notch1, Notch3, and c/EBP- (19, 25) (Fig. 7B). This
raises the possibility that interactions between ORF2 and Notch1,
Notch3, or c/EBP-may influence theDNAbinding properties of
ORF2. It is also possible that interactions betweenORF2 and these
cellular transcription factors interfere with the known functions
of these transcription factors. For example, Notch family mem-
bers must interact with Mastermind and a CSL family member in
the nucleus to activate transcription (37, 39–41). Since ORF2, in
general, interferes with Notch-dependent signaling pathways (25,
26),ORF2may recruitNotch1 orNotch3 to novelDNA sequences
or interfere with interactions between Notch, Mastermind, and
CSL family members. Furthermore, c/EBP- cooperates with the
BHV-1 VP16 homologue to trans-activate viral immediate-early
promoters (24), suggesting that an interaction betweenORF2 and
c/EBP- reduces immediate-early gene expression.
To date, we have no evidence indicating that ORF2 binds DNA
in a sequence-specific fashion. However, we cannot rule out the
possibility that ORF2 can bind specific DNA sequences in the
presence of a neuronal factor or following specific posttransla-
tional modifications. It is also possible that ORF2 preferentially
binds a broad-based consensus sequence that is frequently present
in the viral genome. Our studies suggest that the first 240 amino
acids of ORF2 contain a DNA interaction domain, because two
transposon insertion mutants (ORF2-134 and ORF2-240) were
unable to efficiently interact with DNA. These two transposon
mutants also do not (i) interfere with stimulation of productive
infection or trans-activation of certain viral promoters by Notch1
or Notch 3 (23), (ii) promote neurite growth in Neuro-2A cells
when Notch is present (26), or (iii) inhibit Notch-mediated acti-
vation of the hairy enhancer of split 5 promoter (23). These ob-
servations indicate that there is a correlation between the ability of
ORF2 to interact with DNA and its ability to perform the known
functions of ORF2. Attempts to generate ORF2 deletion mutants
to further localize the DNA binding domain of ORF2 failed be-
cause proteins encoded by the deletionmutants were not stable in
bacteria or in transiently transfected Neuro-2A cells. These nega-
tive results also provide evidence that the half-life of ORF2 is
tightly regulated and has functional significance.
Previous studies concluded that ORF2 is a crucial product en-
coded by the LR gene that promotes the latency reactivation cycle
(reviewed in reference 30). For example, an LRmutant virus con-
taining stop codons at the N terminus of ORF2 induces higher
levels of apoptosis in sensory neurons during the establishment of
latency (21), but the LR mutant virus does not reactivate from
latency following dexamethasone treatment (5). Consequently,
the ability of ORF2 (20, 22, 23) to inhibit apoptosis is proposed to
promote the survival of infected sensory neurons, in particular
during the establishment of latency (21). The ability of ORF2 to
interact with cellular transcription factors, for example, Notch1,
Notch3, and c/EBP- (25, 35), also appears to be important dur-
ing the latency reactivation cycle. These interactions reduced the
ability of Notch1 to stimulate productive infection, the ability of
Notch1 or Notch3 to trans-activate certain viral promoters, and
the ability of Notch1 orNotch3 to inhibit neuronal differentiation
(23, 25, 26). Finally, support for ORF2 playing a role in the latency
reactivation cycle comes from studies demonstrating that the wt
LR gene, but not the ORF2-mutated LR gene, restores wt reacti-
vation levels to an HSV-1 LAT null mutant (42, 43). Collectively,
these studies suggest that ORF2 represses viral transcription and
productive infection during the establishment or maintenance of
latency. In the context of productive infection, ORF2 may not be
important, because the splicing pattern of the LR transcript is
quite different from that in sensory neurons, and thus, intact
ORF2may not be expressed (44). Additional support for this pre-
diction comes from the finding that expression of ORF2 is not
readily detected in productively infected cells until 24 h after in-
fection (18); by then, productive infection is completed and most
cells are dead or dying. The LR gene also encodes twomicro-RNAs
that interfere with bICP0 expression and promote cell survival
(27, 28), indicating that ORF2 is not the only viral factor that
regulates the latency reactivation cycle.
The findings that ORF2 is tightly associated with the nuclear
periphery in transiently transfected cells (23, 25) and that ORF2
interacts with ss- and dsDNA imply that ORF2 recruits the viral
genome to certain subnuclear structures in latently infected neu-
rons. Several studies have concluded that if genes are localized to
the nuclear periphery or nuclear envelope, gene expression is re-
duced or silenced (45–48). The organization of genes at the nu-
clear periphery or nuclear envelope can also lead to activation
depending on factors located at these respective specific sites (re-
FIG 7 Schematic of ORF2 interactions with DNA and cellular transcription
factors. See the text for further details.
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viewed in reference 49). A yeast protein, enhancer of silent chro-
matin 1, localizes to nuclear peripheral areas much like ORF2
does, and the enhancer of silent chromatin 1 protein recruits het-
erochromatin to the nuclear periphery (50–52). If ORF2 recruits
viral genomes to the nuclear periphery, this may interfere with
viral genomes entering replication compartments in infected sen-
sory neurons and consequently promote the establishment and/or
maintenance of latency. ORF2 does not regulate basal levels of the
bICP0 early promoter, the immediate-early promoter that acti-
vates bICP4 and bICP0 expression, or the glycoprotein C pro-
moter in transient-transfection assays (23, 25), suggesting that
ORF2 is not a sequence-specific repressor of transcription. Con-
versely, our studies suggest that ORF2 regulates gene expression
by sequestering specific cellular transcription factors, and this
function may not require sequence-specific binding of ORF2 to
DNA. Studies designed to understand the precise role that the
DNA binding properties of ORF2 play in the latency reactivation
cycle of BHV-1 are under way.
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